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The endocannabinoid system has been implicated in
several neurobiological processes, including neurode-
generation and neuroprotection. The aim of this study
was to evaluate the effects of unilateral retinal ablation
on the expression of the cannabinoid receptor subtype
1 (CB1) at both protein and mRNA levels in the optic
tectum of the adult chick brain. After different survival
times postlesion (2–30 days), the chick brains were
subjected to immunohistochemical, immunoblotting,
and real-time PCR procedures to evaluate CB1 expres-
sion. TUNEL and Fluoro-Jade B were used to verify the
possible occurrence of cell death, and immunostaining
for the microtubule-associated protein MAP-2 was per-
formed to verify possible dendritic remodeling after
lesions. No cell death could be observed in the deaffer-
ented tectum, at least up to 30 days postlesion,
although Fluoro-Jade B could reveal degenerating
axons and terminals. Retinal ablation seems to gener-
ate an increase of CB1 protein in the optic tectum and
other retinorecipient visual areas, which paralleled an
increase in MAP-2 staining. On the other hand, CB1
mRNA levels were not changed after retinal ablation.
Our results reveal that CB1 expression in visual struc-
tures of the adult chick brain may be negatively regu-
lated by the retinal innervation. The increase of CB1 re-
ceptor expression observed after retinal removal indi-
cates that these receptors are not presynaptic in retinal
axons projecting to the tectum and suggests a role of
the cannabinoid system in plasticity processes ensuing
after lesions. VC 2008 Wiley-Liss, Inc.
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The endocannabinoid system comprises endocanna-
binoid molecules, their synthetic and degradation
enzymes, and their receptors, and it has been implicated
in several neural processes, such as cognition, antinoci-
ception, sleep, feeding, and modulation of synaptic trans-
mission of other neurotransmitter systems (Matsuda
et al., 1990; Piomelli, 2003; Di Marzo and Matias, 2005;
Chevaleyre et al., 2006; Hashimotodani et al., 2007).
The modulator role of cannabinoid system has been sug-
gested in several studies aimed at determining the ana-
tomical distribution of the receptors and analyzing the
pharmacological effects of cannabinoid compounds
(Pertwee, 1997, 2001; Ameri, 1999; Fernandez-Ruiz
et al., 2000; Fride, 2002, 2004; Howlett et al., 2002,
2004). For instance, the predominant presynaptic local-
ization of cannabinoid receptors suggests their participa-
tion in retrograde signaling at g-aminobutyric acid
(GABA)-ergic and glutamatergic neurons, with conse-
quences for plasticity processes such as learning and
memory (Freund et al., 2003; Piomelli, 2003). In addi-
tion, the endocannabinoid system has also been impli-
cated in brain development, neuroprotection, and plas-
ticity processes (Fernande´z-Ruiz et al., 2000; Grundy
et al., 2001; Panikashvili et al., 2001, 2005, 2006;
Parmentier-Batteur et al., 2002; Ramos et al., 2002;
Mato et al., 2003; Ashton et al., 2004; Begbie et al.,
2004; Karanian et al., 2005; Leonelli et al., 2005; Cheva-
leyre et al., 2006; Gilbert et al., 2007).
Several studies demonstrated increased levels of
endocannabinoids and up-regulation of CB1 receptors in
brain damage models in rats and mice (Romero et al.,
2000; Hansen et al., 2001; Panikashvili et al., 2001; van
der Stelt et al., 2001; Unzicker et al., 2005). The
observed accummulation of endocannabinoids and CB1
up-regulation could represent a protective response con-
tributing to rescue neurons from death. Taken together
with the receptor reduction observed in neurodegenera-
tive diseases such as Huntington’s disease (Glass et al.,
2000) and the symptomatic relief provided by cannabi-
noids in experimental models of chronic neurodegenera-
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tive diseases (Grundy et al., 2001), those data are sugges-
tive of a neuroprotective effect of cannabinoids.
The endocannabinoid system has also been pointed
out as an important system in plasticity processes of the
central nervous system. Karanian and collaborators
(2005) describe the participation of CB1 receptor in the
generation of important signals for the maintenance of
synapses in the hippocampus of rats. In summary, canna-
binoids activate pathways related to cell survival and in-
hibit signals that could compromise synaptic integrity,
involving endogenous compensatory systems. Another
study suggests that the CB1 receptor could contribute to
the neurochemical control of vestibular system plasticity
after unilateral deafferentation, without requiring changes
in the CB1 protein expression (Ashton et al., 2004).
In addition, Tagliaferro and collaborators (2006) demon-
strate changes of cytoskeletal and synaptic density ele-
ments in several rat brain regions after chronic treat-
ment with a CB1 receptor agonist, again suggesting
the involvement of the cannabinoid system in neural
plasticity.
As part of a general effort to understand the central
consequences of retinal lesions (Britto et al., 1994; Pires
et al., 1998, 2000; Torra˜o and Britto, 2004), the aim of
this study was to verify the effects of unilateral retinal
ablation on the expression of the CB1 receptor in pri-
mary visual areas of the chick brain, especially the optic
tectum (Leonelli et al., 2005). We also tested the pre-
sumptive occurrence of cell death after retinal ablation
using the in situ DNA fragmentation staining method,
terminal deoxynucleotidyl transferase (TdT)-mediated
dUTP-fluorescein nick end labeling (TUNEL; Gavrieli
et al., 1992), and the Fluoro-Jade B technique (Schmued
and Hopkins, 2000). In addition, microtubule-associated
protein-2 (MAP-2) immunohistochemistry was used to
verify possible dendritic changes after deafferentation.
The chick visual system is especially well suited for such
an analysis, insofar as there is a virtually complete cross-
ing of retinal fibers, which generates control and experi-
mental tecta in the same subject (Britto et al., 1994;
Torra˜o and Britto, 2004). Furthermore, both retinal
neurons and central visual structures express CB1 recep-
tors in several vertebrate classes (Porcella et al., 1998;
Bisogno et al., 1999; Straiker et al., 1999a,b; Yazulla
et al., 1999; Leonelli et al., 2005). The present approach
generated a framework of data that may be suitable to
test the role of endocannabinoids in plasticity processes.
MATERIALS AND METHODS
Retinal Lesions
Seventy-nine 15-day-old chicks (Gallus gallus) were
obtained from a local hatchery and used in this study. The
chicks were anesthetized with ketamine (5 mg/100 g of body
weight, i.m.) and xylazine (1 mg/100 g, i.m.) and subjected
to unilateral retinal ablation as described previously (Torra˜o
and Britto, 2004). Briefly, the lens and vitreous were
removed, and the neural retina was completely destroyed and
removed with cotton swabs. A piece of absorbable gelatin
(Gelfoam; Upjohn, Kalamazoo, MI) was placed inside the eye,
and the eyelids were sutured. Most of these animals were used
for CB1 and MAP-2 immunohistochemistry (n 5 24) or
TUNEL and Fluoro-Jade B studies (n 5 15). To obtain some
additional information on CB1 protein and mRNA expres-
sion, additional groups of chicks were used for immunoblot-
ting (n 5 28) and for RT-PCR (n 5 12) experiments,
respectively. The experiments were carried out in accordance
with the guidelines of the Brazilian College for Animal Exper-
imentation (COBEA) and were approved by The Ethics
Committee for Animal Research of the University of Sa˜o
Paulo.
Perfusion
After distinct survival times postlesion (2, 7, 15, and 30
days), the chicks were deeply anesthetized with ketamine and
xylazine and perfused through the heart with phosphate-buf-
fered saline (PBS) and 2% (for immunohistochemistry) or 4%
paraformaldehyde (for TUNEL and Fluoro-Jade B) in 0.1 M
phosphate buffer (PB; pH 7.4). Brains were removed from the
skull and postfixed for 3 hr for immunohistochemistry or 6 hr
for histochemical studies, then transferred to a 30% sucrose
solution in PB to ensure cryoprotection. Coronal sections
(30 lm) of the frozen brains were cut on a sliding microtome
and subjected to immunohistochemistry, TUNEL, and Flu-
oro–Jade B.
TUNEL and Apoptosis
Brain sections were mounted on gelatin- and chromoa-
lumen-coated slides, washed in 0.05 M PBS (pH 7,4), and
then incubated in a solution containing 0.1% Triton X-100
and 0.1% sodium citrate in 0.05 M PBS for 2 min in ice. The
material was washed and incubated with a TUNEL kit mix-
ture (Roche Molecular Biochemicals, Mannheim, Germany)
for 60 min at 378C. After the reaction, the sections were
washed and, coverslipped using VectaShield (Vector, Burlin-
game, CA), and analyzed on a fluorescence microscope
equipped with a standard fluorescein filter.
Fluoro-Jade B and Neurodegeneration
Brain sections were mounted on gelatin- and chromoa-
lumen-coated slides and air dried on a slide warmer. The ma-
terial was immersed in a solution containing 1% sodium hy-
droxide in 80% alcohol for 5 min and in 70% alcohol fol-
lowed by distilled water for 2 min. The slides were then
transferred to a solution of 0.06% potassium permanganate for
10 min, under agitation, to ensure reduction of background
staining and washed in distilled water for 2 min. The material
was then incubated in a solution of 0.001% Fluoro-Jade B
(Chemicon, Temecula, CA) in 0.1% acetic acid for 20 min,
and washed three times in distilled water. The slides were
placed on a slide warmer until they were fully dry, cleared by
immersion in xylene for 2–3 min, and coverslipped using
DPX (Fluka, Milwaukee, WI). Finally, the material was ana-
lyzed on a fluorescence microscope equipped with a standard
fluorescein filter.
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Immunohistochemistry
Free-floating sections were incubated overnight with a
rabbit polyclonal antiserum against the extracellular N-termi-
nal portion of the CB1 receptor (Cayman, Ann Arbor, MI)
diluted 1:1,000 or a mouse monoclonal antibody against
MAP-2 (Chemicon) diluted at 1:2,000. Both antibodies were
diluted in PB containing 0.3% Triton X-100 plus 5% of nor-
mal goat (for the rabbit polyclonal antiserum) or normal don-
key sera (for the mouse monoclonal antibody). After three
washes in PB, the sections were incubated for 2 hr with a bi-
otinylated goat anti-rabbit or donkey anti-mouse sera (Vector)
diluted 1:200 in PB containing 0.3% Triton X-100. The sec-
tions were washed again in PB and incubated for 1 hr with
the avidin-biotin-peroxidase complex (ABC Elite; Vector).
The sections were then reacted with 0.05% 3-30-diaminoben-
zidine and a 0.01% solution of hydrogen peroxide in PB and
intensified with 0.05% osmium tetroxide in water. Finally, the
sections were mounted on gelatin- and chromoalumen-coated
slides, dehydrated, cleared, and coverslipped with Permount
(Fisher, Pittsburgh, PA). Controls for the specificity of staining
included the omission of the primary antibody and substitu-
tion of the primary antibody for appropriate normal sera. The
material was then analyzed with a light microscope, and digital
images were collected.
A densitometric analysis was performed on the immuno-
labeled material in NIH Image software. The average optical
density of labeled areas of the control and experimental optic
tecta for CB1 receptor immunoreactivity for each time point
was evaluated with the routine ‘‘density slice’’. In summary,
nine tectal fields in total in three sections/animal through the
superficial layers of the optic tectum were subjected to quanti-
tative analysis. Mean values 6 SEM obtained from densito-
metric analysis were statistically analyzed by two-way
ANOVA followed by the Tukey test. For all comparisons,
P < 0.05 was considered significant.
Immunoblotting
After the same survival times as described above, the
chicks were sacrificed by cervical dislocation, and the tecta
were rapidly collected and homogenized at 48C in an extrac-
tion buffer (Tris, pH 7.4, 100 mM; EDTA 10 mM; PMSF
2 mM; aprotinin 0.01 mg/ml). The homogenates were sub-
jected to centrifugation at 12,000g for 20 min, and the protein
concentration of the supernatant was determined using a pro-
tein assay (Bio-Rad, Hercules, CA). Samples from the ho-
mogenate containing 75–100 lg protein were subjected to a
10% acrylamide gel containing sodium dodecyl sulfate and
electrotransferred to nitrocellulose membranes using a Trans-
Blot cell system (Bio-Rad). The nitrocellulose membranes
were then blocked for at least 2 hr and incubated overnight
with the same antibody against CB1. Loading control with b-
actin was conducted in all experiments by using an anti-b-
actin antibody (Sigma, St. Louis, MO). The specifically bound
antibody was visualized using a chemiluminescence kit (ECL
Kit; Amersham Biosciences, Little Chalfont, Buckinghamshire,
United Kingdom). Finally, the blots were densitometrically
analyzed in Scion Image 4.0.2 (Scion Corporation, Frederick,
MD) and statistically treated as described for immunohisto-
chemistry. Because there were no b-actin changes after retinal
ablation under our conditions, the optical density of the CB1
bands was first normalized in relation to the corresponding b-
actin bands in each experiment. Subsequently, the normalized
data were treated to evaluate protein changes in the experi-
mental tecta in relation to their controls for each time point.
The data were then subjected to a two-way analysis of var-
iance followed by the post hoc Tukey test as described above.
Real-Time PCR
After survival times of 2, 7, and 15 days, which seemed
to produce noticeable effects in preliminary immunohisto-
chemical and immunoblotting experiments, a group of animals
was sacrificed for RNA extraction by cervical dislocation, and
each optic tectum (total of 100 mg) was rapidly collected and
total RNA isolated using the Trizol reagent (Invitrogen Life
Technologies, Carlsbad, CA), following the manufacturer’s
recommendations. These samples were dissolved in free ultra-
filtered water, and their concentrations were determined by
measuring absorbance at 260 nm. The purity of the RNA was
determined by calculating the 260/280 nm ratio, and the
RNA integrity was checked on a 1% agarose gel stained with
ethidium bromide. Reverse transcription (RT) reaction was
done with 5 lg of the total RNA containing oligo-dt
(500 lg/ml), 10 mM of each dNTP, 53 First-Strand Buffer,
0.1 M dithiothreitol (DTT), and 200 U reverse transcriptase
(SuperScript II; Invitrogen). RT reaction was performed at
708C for 10 min, followed by 428C for 60 min and 10 min at
958C.
Oligonucleotide primers were designed in Primer
Express Software (Applied Biosystems, Foster City, CA) and
synthesized by Dialab (Sa˜o Paulo, Brazil). The sequences used
were: cannabinoid receptor type 1 gene from Gallus gallus
(forward: 50-TATCCTCCACTCCCGAAGCCTG-30; re-
verse: 50-AAACGCAACGACAGCCTTTGG-30) and b-actin
as an endogenous control (forward: 50-CCAACACAGTGC
TGTCTGGTGG-30; reverse: 50-TTTGCGGTGGACAATG-
GAGG-30).
The real time PCR amplifications were performed using
10–80 ng/ll of each RT reaction product diluted in a reac-
tion buffer containing 25 ll of Sybr green (Invitrogen, Carls-
bad, CA) as fluorescent dye, 200 nM primers (forward and
reverse) in a final volume of 50 ll per sample, divided in two
wells (duplicate). Cycling conditions were set as follows: an
initial activation step at 958C for 15 min, 40 cycles of 15 sec
of denaturation at 958C, and 60 sec of annealing at 588C,
then melt curve analysis was performed by heating samples
from 658C to 998C (18C increment changes at 5-sec inter-
vals). The relative values of mRNA levels of the tested gene
(CB1), comparing all samples and controls in duplicate, is
based on real-time detection of PCR products by measuring
fluorescence quantified with the Rotor Gene 3000 equipment
(Corbett Research, Mortlake, Australia), based on current
methodology (Bustin, 2000). The relative quantification value
of each target gene was analyzed using a comparative Ct
method (Livak and Schmittgen, 2001). All quantifications
were normalized to an endogenous control gene (b-actin).
The Ct values of samples and controls were adjusted initially
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for the amount of the CB1 gene, b-actin gene (DCt; Ct of
sample or control – Ct of b-actin), and then compared with
the medium control by subtracting its dCt to yield a DDCt.
The final values for samples are reported as a -fold difference
relative to the expression of the mean of the control (calcu-
lated as 2–DDCt), with the mean of the control arbitrarily set to
1. Results were expressed as the ratio of the mRNA level of
the CB1 gene in relation to the mRNA level of b-actin.
Mean values 6 SEM were statistically analyzed using the two-
way ANOVA followed by the Tukey test as described above.
RESULTS
TUNEL and Fluoro Jade B
Retinal ablation does not seem to generate cell
death by apoptosis in the optic tectum; the TUNEL
method used here showed no labeled nuclei in either
the contralateral or the ipsilateral optic tectum (data not
shown). On the other hand, a neurodegenerative process
could be identified in retinal axons and their central ter-
minations in visual areas by the Fluoro-Jade B method.
This process was characterized by the presence of stained
fibers and puncta and was especially noticeable after 7
days postlesion (Fig. 1).
CB1 Protein and mRNA Expression in the Optic
Tectum After Retina Removal
In general, CB1 immunoreactivity was observed
almost exclusively in the neuropil of visual structures. In
the control optic tectum, the staining was seen mainly in
the most superficial layers, specifically in Cajal’s layers 2–
3 and 5, and was more intense in layers 2–3. The deep-
est layers showed a moderate immunoreactivity for CB1.
The unilateral retinal ablation produced an increase
in the immunoreactivity for CB1 in the neuropil of su-
perficial layers of the contralateral (deafferented) optic
tectum, in all layers containing CB1. These results were
observed for all survival times, and the statistical data for
the mean optical density of staining are summarized in
Table I.
The retinal ablation produced marked effects on
the CB1 immunostaining, namely, an increase of about
56% (Fig. 2), 52%, and 93% after 7, 15, and 30 days,
respectively. However, it should be stressed that a
marked reduction in the size of optic tectum generated
Fig. 1. Histochemistry for Fluoro-Jade B in fibers of retinal origin located in the main optic tract
(OT) and the basal optic root (BOR). Staining in the deafferented side is indicative of fiber degen-
eration. A few fibers and varicosities are also seen in the control side and probably represent a small
contingent of degenerating ipsilateral retinal fibers. Scale bar 5 100 lm.
TABLE I. Effects of Retinal Ablation on CB1 Immunoreactivity in the Chick Optic Tectum
y
CB1 staining (optical density) 2 Days (n 5 7) 7 Days (n 5 6) 15 Days (n 5 6) 30 Days (n 5 5)
Control 311.0 6 10.48 230.9 6 7.99 240.0 6 9.66 142.5 6 12.31
Deafferented 332.0 6 10.71 353.2 6 10.26* 346.2 6 11.48* 250.6 6 15.42*
yData are given as average of the absolute numbers of the CB1 optical density and standard error of the means. The control always refers to the ipsilat-
eral tectum in relation to the ablated retina, and deafferented to the contralateral side. The data were submitted to Paired t-test. The comparisons and
analyses of significance involved only the control with the deafferented side of the same survival period. The apparent variation of data for the control
side probably was due to the increase of the optic tectum with age. (please see text).
*P < 0.001.
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by the ablation after longer survival times (especially 15
and 30 days) was clearly visible, and this shrinkage has
not been considered when analyzing the immunolabeling
results. After 15 days postablation, the shrinkage of tectal
layers in the contralateral side was about 31%, and after
30 days it was about 47%.
The optical density data actually revealed an appa-
rent decrease of immunostaining in the control tectum
along the time points, which could suggest a reduction
of CB1 with age. However, insofar as this effect was not
observed for the immunoblotting data (see below), it is
likely that the decrease in optical density is related to the
increase in the optic tectum with age.
This increase rendered difficult the comparison of
absolute optical density values along the different time
points tested. The normalized values of the CB1 increase
after retinal ablation shown in Figure 3 reveal, however,
that the CB1 up-regulation was very clear along the dif-
ferent time points, regardless of the optic tectum size.
The normalized data for the effects of unilateral retinal
ablation after all survival times are depicted in Figure 3.
As observed with the immunohistochemical
method, the unilateral retinal ablation also appeared to
produce changes in CB1 expression in the immunoblot-
ting experiments (Fig. 4). The optic tectum contralateral
to the retinal ablation showed a significant increase of
CB1 expression in relation to the control tectum after 7
and 15 days of about 22% (22.19% 6 8.67%, P < 0.05)
and about 50% (50.06% 6 15.84%, P < 0.01), respec-
tively. Unlike what was observed for protein levels, uni-
lateral retinal ablation did not produce any detectable
changes of CB1 mRNA levels after 2, 7, or 15 days of
survival time (Fig. 5).
MAP-2 Expression in the Optic Tectum
After Retina Removal
MAP-2 expression was detected in the control tec-
tum as stained processes encompassing several layers of
the superficial and intermediate tectum, especially in
layers 2–4, 5b, and 8–10. In the intermediate layers, the
most prominent staining occurred in radial dendrites,
which sometimes reach the superficialmost layers 2–3.
All of those tectal layers included occasional labeled peri-
karya. After retinal lesions, a marked increase of MAP-2
staining was observed in the deafferented tectum. This
increase was more pronounced in layers 2–3 and espe-
cially 5b, whereas the vertical dendrites appeared to be
reduced in their numbers and partially to lose their radial
Fig. 3. Effects of unilateral retinal ablation upon the CB1 protein
expression in the chick optic tectum evaluated by immunohisto-
chemistry. The graph depicts the percentage changes of CB1 expres-
sion after 2, 7, 15, and 30 days postablation in relation to the control
optic tecta for each time point. Expression of CB1 exhibited a statisti-
cally significant increase after 7, 15, and 30 days (*P < 0.001). It
should be mentioned that a marked tectal shrinkage occurred after 30
days postlesion (see text).
Fig. 2. Immunohistochemical staining for CB1 in the chick optic tectum 7 days after unilateral ret-
inal ablation. Staining in the deafferented side is markedly increased. Numbers refer to tectal layers,
according to Cajal’s scheme. Scale bar 5 250 lm.
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organization (Fig. 6). The MAP-2 increase was more
noticeable after 7 days postlesion.
DISCUSSION
The data from the present study suggest that tectal
deafferentation of its major afferent source induces an
up-regulation of CB1 that appears not to be dependent
on increased mRNA levels. Although there is no evi-
dence that the protein increase involves functional
receptors, the CB1 increase could be the result of
reduced degradation or of mobilization of receptors from
a precursor cytoplasmic pool, which is not recognized
by the anti-CB1 antibody under control conditions. The
CB1 up-regulation could be related either to cell death
resulting from deafferentation and/or to tectal plasticity
in response to retinal removal. Our data with TUNEL
and Fluoro-Jade B suggest, however, that there is no cell
death in the tectum in the present model. This appears
to favor the hypothesis that the CB1 up-regulation may
be more related to plasticity processes that occur in the
deafferented tectum.
The present data, besides adding information on
the functional organization of the cannabinoid system,
also generated information about the localization of the
CB1 receptors in the retinotectal system. These receptors
are expressed only in the neuropil of superficial tectal
layers (Leonelli et al., 2005) and, as such, they could
constitute presynaptic receptors on retinal ganglion cell
terminals. Indeed, retinal ganglion cells of the chick ret-
ina and other species do express CB1 receptors (Straiker
et al., 1999a,b), which could be exported to their central
terminals. Alternatively, those receptors in the tectum
could participate in plasticity events after the retinal re-
moval as postsynaptic receptors in different tectal layers.
Several studies have shown the presynaptic localization
of cannabinoid receptors on GABA-ergic and glutama-
tergic neurons, suggesting a participation in plasticity
processes (Freund et al., 2003; Piomelli, 2003). Although
most of these studies indicate a presynaptic localization
of cannabinoid receptors, the increase of the CB1
expression in tectal layers of the chick brain after retinal
ablations observed in the present study is suggestive of a
postsynaptic location, maybe as part of the internal tec-
tum circuitry. This hypothesis is corroborated by the fact
that, even after longer survival times of the ablation (15
and 30 days), CB1 expression still seems to be increased.
Besides the general idea of a presynaptic location of can-
nabinoid receptors, other studies support the hypothesis
of an intrinsic location of those receptors, because their
authors did not find any changes of receptor binding or
immunoreactivity in several hypothalamic and vestibular
regions, respectively, after deafferentation (Romero
et al., 1998; Ashton et al., 2004). However, we cannot
exclude the possibility that CB1 receptors are presynaptic
on axon terminals from other tectal afferent sources.
Likewise, the possibility that the retinal endocannabinoid
system (Porcella et al., 1998; Bisogno et al., 1999;
Yazulla et al., 1999) influences the tectal function
remains to be investigated.
In a recent study from our laboratory, we showed
a similar up-regulation effect for another chemically
defined system, namely, an increase of the neuronal iso-
form of nitric oxide synthase in the tectum after retinal
removal (Torra˜o and Britto, 2004). These data suggest
Fig. 5. Expression of CB1 mRNA in the optic tectum evaluated by
real-time PCR. The graph depicts the normalized CB1 mRNA
expression after 2, 7, and 15 days postablation in relation to the con-
trol optic tecta for each time point.
Fig. 4. Effects of unilateral retinal ablation on the CB1 protein expression
in the chick optic tectum evaluated by immunoblotting experiments. A:
Representative immunoblots of CB1 of the control tectum (C) and at 2, 7,
15, and 30 days (2d, 7d, 15d, and 30d, respectively) after ablation are shown
in the upper row. Loading control with b-actin immunoreactivity is seen
in the lower row. B: Graph showing the percentage changes of CB1
expression after 2, 7, 15, and 30 days postablation in relation to the control
optic tecta for each time point. Expression of CB1 exhibited a statistically
significant increase after 7 days (*P< 0.05) and 15 days (**P< 0.01).
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that, similar to the nitrinergic system, the endocannabi-
noid system in the tectum is normally under negative
regulation by retinal activity, and its up-regulation after
retinal ablation may be involved in plasticity processes.
Many studies suggest the participation of the endo-
cannabinoid system in neuroprotection and neurodegen-
eration processes by the use of different models of neu-
ronal injuries both in vitro and in vivo (Hansen et al.,
2002; Parmentier-Batteur et al., 2002; van der Stelt
et al., 2002), and at least part of this protection seems to
occur by the activation of the CB1-type of cannabinoid
receptors (Panikashvili et al., 2001, 2005; Parmentier-
Batteur et al., 2002). For example, Panikashvili and col-
laborators (2001) have shown an increase in the levels of
the endocannabinoid 2-arachidonoyl-glycerol (2-AG) af-
ter closed head injury in mice, and the beneficial effect
of 2-AG was dose dependently attenuated by SR-
141761A, an antagonist of the CB1 cannabinoid recep-
tor. In another study, it was suggested that CB1 recep-
tors have a role in neuroprotective processes, insofar as
CB1 receptor knockout mice showed an increased mor-
tality after permanent focal cerebral ischemia (Par-
mentier-Batteur et al., 2002). However, the neuropro-
tective effects of the endocannabinoids are still under
debate, because studies on cell cultures were not able to
confirm that protective effect (Nilsson et al., 2003). Our
results may corroborate the idea of a possible neuropro-
tective role of the endocannabinoid system and that part
of this protection mechanism seems to be mediated by
CB1 receptor, insofar as this receptor was increased in
the optic tectum after deafferentation. Panikashvili and
collaborators (2001) showed a transient increase of the
2-AG levels after closed head injury in mice. They
observed that the level of 2-AG was increased after the
first hours, peaked about 4 hours after the lesion, and
was still increased 24 hr after the lesion. Our data are in
agreement with a transient protection hypothesis for the
endocannabinoid system; we observed a peak of CB1
expression after 7 days of survival time in visual struc-
tures. Several studies indeed demonstrate increased levels
of endocannabinoids and up-regulation of CB1 receptors
in brain injury models in rats and mice (Romero et al.,
2000; Hansen et al., 2001; Panikashvili et al., 2001; van
der Stelt et al., 2001; Unzicker et al., 2005). For exam-
ple, Hansen and collaborators (2001), using rats with
mild neurodegenerative processes induced by changes of
glutamatergic neurotransmission and of endocannabinoid
homeostasis, found higher levels of anandamide, but not
of 2-AG, and increased binding and mRNA of CB1
receptors. Interestingly, Romero and collaborators
(2000) found a significant increase of CB1 mRNA levels,
but not receptor binding, in basal ganglia of rats sub-
jected to lesion of nigrostriatal dopaminergic neurons.
Our results, on the other hand, revealed changes of CB1
protein levels but not of the CB1 mRNA after retinal
ablation, suggesting a posttranscriptional mechanism of
receptor mobilization. These distinct results found by
different groups could be interpreted to mean that the
regulation of the endocannabinoid system is very com-
plex and/or depends on the model and brain area tested.
Although several recent studies support the neuro-
protection effects of the endocannabinoid system in dis-
tinct neurotoxicity models, the exact mechanims
involved in this process are still unknown (Marsicano
et al., 2002). It is interesting to mention that Khaspekov
and coleagues (2004) suggested a participation of neuro-
trophic factors in neuroprotection events triggered by
the activation of CB1 receptors.
The endocannabinoid system has also been pointed
out as an important system in plasticity processes of the
central nervous system. Karanian and collaborators
(2005) describe the participation of CB1 receptor in the
generation of important signals for the maintenance of
synapses in the hippocampus of rats. Then, the increase
of CB1 expression observed here could represent a par-
ticipation of endocannabinoid system in the maintenance
of synaptic integrity. Another study suggests a participa-
tion of CB1 receptor in the control of the vestibular sys-
Fig. 6. Immunohistochemical staining for MAP-2 in the chick optic tectum 7 days after unilateral
retinal ablation. Staining in the deafferented side is markedly increased. Numbers refer to tectal
layers, according to Cajal’s scheme. Scale bar 5 200 lm.
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tem plasticity after unilateral deafferentation (Ashton
et al., 2004). Unlike our present results, the latter
authors suggest plasticity-related effects of CB1 that do
not require changes of protein expression. In addition,
Tagliaferro and collaborators (2006) demonstrate changes
in cytoskeletal and synaptic density elements after
chronic treatment with a CB1 receptor agonist. Taken
together with the present data, this bulk of information
contributes to link the endocannabinoid system to plas-
ticity processes. In the present study, the increase of CB1
receptor expression could thus be involved in a plastic
remodeling of the visual system after retinal removal. It
is very tempting to speculate that the increase of MAP-2
staining in much the same layers that express CB1, and
with a similar time course, could be dependent of an
effect of these receptors on the dendritic reorganization
that ensues after retinal removal. This hypothesis may be
the subject of additional, combined pharmacological/
morhological experiments.
In summary, our results suggest that CB1 receptors
in the optic tectum of the chick brain are negatively
regulated by the retinal innervation. The increase of
expression observed after retinal removal could be indic-
ative of a participation of the endocannabinoid system in
plasticity processes triggered by deafferentation.
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